Artivion (AORT) Form 4: CCO sell-to-cover 3,373 shares at $44.619

Artivion, Inc. (AORT) reported an insider transaction.

Rhea-AI Filing Summary

Artivion, Inc. (AORT) reported an insider transaction. Chief Commercial Officer John E. Davis disclosed the sale of 3,373 shares of common stock on 11/10/2025 at $44.619 per share.

The filing states the shares were sold upon RSU vesting to cover tax withholding obligations via a sell-to-cover and “does not represent a discretionary transaction.” Following the transaction, Davis directly beneficially owned 205,405 shares.

Insights

Insider trading compliance analyst

Non-discretionary sell-to-cover; neutral signal.

Artivion's CCO, John E. Davis, reported selling 3,373 common shares at $44.619 on 11/10/2025. The note specifies the sale occurred upon RSU vesting to satisfy tax withholding, characterizing it as a sell-to-cover rather than an elective trade.

Such transactions are common around vesting dates and typically do not reflect a directional view on the stock. After the sale, Davis directly held 205,405 shares, indicating continued exposure to company equity.

The filing does not detail broader implications beyond this administrative tax event. Actual market impact depends on holder decisions and normal trading dynamics.

Insider Trade Summary

Net Seller: 3,373 shares

Net Sell 1 txn

Insider Davis John E

Role Chief Commercial Officer

Sold 3,373 shs ($150K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,373	$44.619	$150K

Holdings After Transaction: Common Stock — 205,405 shares (Direct)

Footnotes (1)

1. F1. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AORT report?

The CCO, John E. Davis, sold 3,373 common shares on 11/10/2025 at $44.619 per share.

Why were the Artivion (AORT) shares sold?

The filing says the shares were sold upon RSU vesting to fund tax withholding via a sell-to-cover, not a discretionary trade.

How many AORT shares does the CCO hold after the sale?

Following the transaction, John E. Davis directly beneficially owned 205,405 shares.

What is the role of the reporting person at Artivion (AORT)?

He is the company’s Chief Commercial Officer.

Was this trade part of a trading plan?

The explanation identifies it as a sell-to-cover for taxes upon RSU vesting; it was not described as a discretionary transaction.

What was the transaction code on the Form 4?

The transaction code was S, indicating a sale of securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 08:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davis John E

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		S		3,373(1)	D	$44.619	205,405	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Remarks:

	/s/ John E. Davis	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.